$IVZ

Is Wall Street Bullish or Bearish on Invesco Stock?

On July 13, BMO Capital analyst Brennan Hawken kept a Buy rating on Invesco (IVZ) and raised its price target to $34 from $28. The article cites a mean target of $32.42, about 4.9% above the current share price, and a Street-high target of $37, implying 19.7% upside.

Original reporting
Published Aug 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Wall Street Bullish or Bearish on Invesco Stock? — source image
Decision brief

The 30-second read

$IVZBullishLow
01

Why it matters

The actionable takeaway is sentiment improvement via a higher price target, but there is no new operational or financial disclosure from Invesco itself.

02

Market read

Traders may treat this as a mild bullish sentiment input for IVZ, but it is not a fundamental catalyst in the article.

03

What to watch

The article cites target levels versus current price but does not discuss valuation, fund flows, fee pressure, or risk events that could dominate near-term performance.

Relevance 4/10Novelty 4/10Timing: today’s analyst-target update (no scheduled macro release)

Background

The piece summarizes Wall Street recommendation posture on Invesco and highlights a recent analyst action by BMO Capital.

Company-level read

Ticker impact

$IVZBullishMedium confidence
Context

BMO Capital maintained a Buy on Invesco and raised its price target to $34 from $28, implying a more constructive outlook.

Expected impact

Likely modest support for IVZ sentiment, with limited follow-through unless additional catalysts emerge.

Evidence & confidence

The only new, company-specific fact is an analyst price-target raise; there is no earnings, guidance, or operational update in the text.

Market effects

Marginal read-through for asset managers, but no sector-wide policy or flow data is provided.

No regional market linkage beyond general Wall Street sentiment.

No global macro or cross-border transaction details.

Counterpoint

Analyst target hikes can lag fundamentals; without earnings or guidance, the move may fade quickly.

Key entities

  • Invesco

    Asset manager whose stock is discussed in relation to an analyst rating and price-target change.

  • BMO Capital

    Brokerage that maintained a Buy rating and raised its Invesco price target.

  • Brennan Hawken

    BMO Capital analyst who raised the price target to $34 from $28.

Related articles

$IVZMed

Invesco Ltd. Q2 2026 Earnings Call Summary

Invesco reported Q2 2026 record net long-term inflows of $45.1B and operating margin of 37.5%, citing 17% year-to-date net revenue growth. Management said 30+ products drove over $500M in net inflows, with QQQ contributing $130M incremental net revenue in H1. It targets high-30s operating margin, a 60% payout ratio, and notes $15M quarterly one-time platform costs.

$IVZMed

Invesco (NYSE:IVZ) Surprises With Strong Q2 CY2026

Invesco (NYSE:IVZ) reported Q2 CY2026 results that beat expectations. Revenue rose 65.3% year over year to $1.83 billion, exceeding Wall Street estimates by 37%. Non-GAAP EPS was $0.71, 7.2% above consensus. Assets under management were $2.47 trillion, up 23.4% year over year, and the stock was about $30.37 after the release.